ADIL - Company ID 0001513525
ADIAL PHARMACEUTICALS, INC. trades as ADIL. This page tracks ADIAL PHARMACEUTICALS, INC. through 533 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Major company event | 8-K | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
The largest companies sharing ADIAL PHARMACEUTICALS, INC.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year ADIAL PHARMACEUTICALS, INC. reported a net loss of $7.98M.